Advanced Esophageal Cancer: Pembrolizumab plus Chemotherapy as First-line Therapy

被引：0
|
作者：
Franke, Katharina
机构：
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2021年 / 59卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1255 / +
页数：2
相关论文
共 50 条
  • [41] Cabozantinib plus pembrolizumab as first-line therapy for cisplatin-ineligible advanced urothelial carcinoma (PemCab).
    Jain, Rohit K.
    Swami, Umang
    Bilen, Mehmet Asim
    Boucher, Kenneth M.
    Brown, Jacqueline T.
    Chahoud, Jad
    Gupta, Sumati
    Agarwal, Neeraj
    Sonpavde, Guru P.
    Maughan, Benjamin L.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 539 - 539
  • [42] Cost-effectiveness of pembrolizumab plus axitinib as first-line therapy for advanced renal cell carcinoma
    Zhu, Jiaxin
    Zhang, Tiantian
    Wan, Ning
    Liang, Zhuoru
    Li, Jiahao
    Chen, Xudong
    Liang, Wenhua
    Jiang, Jie
    IMMUNOTHERAPY, 2020, 12 (17) : 1237 - 1246
  • [43] Pembrolizumab plus chemotherapy as first-line treatment in patients with HER2 negative advanced oesogastric adenocarcinoma
    Duval, Martin
    Zaanan, Aziz
    BULLETIN DU CANCER, 2024, 111 (05) : 431 - 432
  • [44] A phase II trial of pembrolizumab plus platinum-based chemotherapy as first-line systemic therapy in advanced penile cancer: HERCULES (LACOG 0218) trial
    Maluf, Fernando Cotait
    Trindade, Karine
    Almeida Preto, Daniel D.
    Marques Monteiro, Fernando Sabino
    Luz, Murilo
    Beato, Patricia Milhomem
    Bastos, Diogo Assed
    Holanda Soares, Joao Paulo
    Lopes dos Santos, Victor Marcondes
    Werneck De Carvalho, Luis Eduardo
    Borges Muniz, David Queiroz
    Racy, Douglas
    Halabi, Susan
    Rebelatto, Taiane Francieli
    Werutsky, Gustavo
    de Jesus, Rafaela Gomes
    Fay, Andre P.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [45] Good Response of Advanced Thymic Carcinoma with Low PD-L1 Expression to Chemotherapy plus Pembrolizumab as First-Line Therapy and to Pembrolizumab as Maintenance Therapy: A Case Report
    Nishii, Yoichi
    Furuhashi, Kazuki
    Ito, Kentaro
    Sakaguchi, Tadashi
    Suzuki, Yuta
    Fujiwara, Kentaro
    Yasuma, Taro
    Kobayashi, Tetsu
    D'Alessandro-Gabazza, Corina N.
    Gabazza, Esteban C.
    Taguchi, Osamu
    Hataji, Osamu
    PHARMACEUTICALS, 2022, 15 (07)
  • [46] Cost-effectiveness of camrelizumab plus chemotherapy versus chemotherapy alone as first-line therapy in advanced or metastatic esophageal squamous cell carcinoma
    Gong, Jinhong
    Shang, Jingjing
    Su, Dan
    Qian, Xiaodan
    Liu, Guangjun
    Sun, Zhiqiang
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (06) : 709 - 717
  • [47] First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial
    Marth, Christian
    Moore, Richard G.
    Bidzinski, Mariusz
    Pignata, Sandro
    Ayhan, Ali
    Rubio, M. Jesus
    Beiner, Mario
    Hall, Marcia
    Vulsteke, Christof
    Braicu, Elena Ioana
    Sonoda, Kenzo
    Wu, Xiaohua
    Frentzas, Sophia
    Mattar, Andre
    Lheureux, Stephanie
    Chen, Xiaojun
    Hasegawa, Kosei
    Magallanes-Maciel, Manuel
    Choi, Chel Hun
    Shalkova, Mariia
    Kaen, Diego
    Wang, Peng-Hui
    Berger, Regina
    Okpara, Chinyere E.
    Mckenzie, Jodi
    Yao, Lili
    Orlowski, Robert
    Khemka, Vivek
    Gilbert, Lucy
    Makker, Vicky
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (09)
  • [48] First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811
    Chung, Hyun Cheol
    Bang, Yung-Jue
    S Fuchs, Charles
    Qin, Shu-Kui
    Satoh, Taroh
    Shitara, Kohei
    Tabernero, Josep
    van Cutsem, Eric
    Alsina, Maria
    Cao, Zhu Alexander
    Lu, Jia
    Bhagia, Pooja
    Shih, Chie-Schin
    Janjigian, Yelena Y.
    FUTURE ONCOLOGY, 2021, 17 (05) : 491 - 501
  • [49] Carboplatin plus paclitaxel as first-line chemotherapy in previously untreated advanced ovarian cancer
    duBois, A
    Luck, HJ
    Meier, W
    Mobus, V
    Costa, S
    Richter, B
    Bauknecht, T
    Warm, M
    Schroeder, W
    Olbricht, S
    Nitz, U
    Jackisch, C
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 28 - 33
  • [50] Pembrolizumab With or Without Maintenance Olaparib for Metastatic Squamous NSCLC That Responded to First-Line Pembrolizumab Plus Chemotherapy
    Hochmair, Maximilian
    Schenker, Michael
    Dols, Manuel Cobo
    Kim, Tae Min
    Ozyilkan, Ozgur
    Smagina, Maria
    Leonova, Viktoriya
    Kato, Terufumi
    Fedenko, Alexander
    De Angelis, Flavia
    Rittmeyer, Achim
    Gray, Jhanelle E.
    Greystoke, Alastair
    Aggarwal, Himani
    Huang, Qinlei
    Zhao, Bin
    Lara-Guerra, Humberto
    Nadal, Ernest
    JOURNAL OF THORACIC ONCOLOGY, 2025, 20 (02) : 203 - 218
12345